MedSpeed Taps M&A Veteran Ross Lieb as CFO to Drive Strategic Growth
- $1.34 billion: Ross Lieb previously led the sale of Antylia Scientific for this amount.
- $100 million: Lieb oversaw five acquisitions adding over this revenue during his tenure at Antylia Scientific.
- 100 hubs: MedSpeed operates across 33 states with over 100 hubs.
Experts would likely conclude that Ross Lieb's appointment as CFO positions MedSpeed for accelerated growth through strategic M&A and operational excellence, leveraging his proven track record in high-value transactions and financial leadership.
MedSpeed Taps M&A Veteran Ross Lieb as CFO to Drive Strategic Growth
ELMHURST, IL โ March 26, 2026 โ MedSpeed, a leading provider of same-day logistics for the healthcare industry, has appointed Ross Lieb as its new chief financial officer. The move signals a strategic intensification of the company's growth ambitions, bringing in a leader with a formidable track record in corporate finance, operational improvement, and high-stakes mergers and acquisitions.
Lieb will take the helm of MedSpeed's financial strategy, planning, analytics, and capital management. His appointment comes at a pivotal time for the company, which recently secured a significant investment from private equity firm Water Street Healthcare Partners in August 2024. This combination of fresh capital and new financial leadership suggests MedSpeed is positioning itself for a period of accelerated expansion and enhanced operational capability in the increasingly complex healthcare logistics market.
"Ross brings a powerful combination of financial rigor and true operational partnership to MedSpeed," said Jake Crampton, CEO of MedSpeed. "Throughout his career, he has helped turn insight into action that strengthens performance, efficiency, and customer value. We're excited for the leadership Ross will add to our team as we continue advancing our mission of delivering health for our customers and the patients they serve."
A Strategist for Expansion
Lieb's professional history underscores a clear focus on strategic growth. He joins MedSpeed from Antylia Scientific, where he served as vice president, interim CFO, and head of M&A. During his tenure, he played a central role in guiding the company through major strategic initiatives, including leading the $1.34 billion sale of the company to Brookfield Asset Management and overseeing five acquisitions that collectively added over $100 million in revenue. This experience in executing large-scale transactions and integrating new businesses will be invaluable as MedSpeed navigates its own growth trajectory.
Before Antylia, Lieb honed his skills in financial planning and performance improvement in leadership roles at EVRAZ North America and in corporate restructuring at Deloitte. His background, complemented by an MBA from The University of Chicago Booth School of Business, equips him to manage not just the balance sheet, but also the strategic levers that drive enterprise value.
The timing of his arrival is critical. Backed by the Water Street investment, MedSpeed is expected to pursue both organic growth and potential acquisitions. Lieb's M&A acumen will be instrumental in identifying, evaluating, and integrating target companies that can expand MedSpeed's geographic footprint, service offerings, or technological capabilities. This strategic approach is essential for a company that has already grown from a Chicago startup to a national enterprise with over 100 hubs across 33 states.
The Modern CFO: Driving Value Beyond the Numbers
Lieb's appointment also reflects the evolving role of the CFO in a data-intensive industry. The modern financial chief is no longer just a guardian of the company's coffers but a key strategic partner who leverages data to drive operational excellence. This shift is particularly relevant in the logistics sector, where efficiency, optimization, and real-time decision-making are paramount.
In his own statement, Lieb emphasized this modern approach. "I'm honored to step into the CFO role at MedSpeed and be part of a team that is deeply committed to supporting patient care every day," he said. "By building on MedSpeed's collaborative culture and continuous improvement mindset, and further strengthening our analytics, we can support operational excellence, grow the organization, and deliver even greater value to our health care customers."
This focus on analytics aligns with broader industry trends. The healthcare logistics market, projected to reach nearly $180 billion by 2032, is rapidly adopting AI-driven inventory systems, IoT for real-time tracking, and advanced data analytics to improve visibility and reduce waste. MedSpeed has already shown its commitment to this technological frontier with the recent appointment of Dhiraj Patkar as its Chief Product and Technology Officer. The synergy between a tech-focused product chief and a data-savvy CFO like Lieb creates a powerful leadership duo capable of transforming transportation from a cost center into a strategic, data-driven asset.
Navigating a Critical and Complex Sector
MedSpeed operates at the heart of the U.S. healthcare system, a sector defined by high stakes and immense complexity. The company's network is the circulatory system for its clientsโ29 of the top 100 health systems in the countryโmoving critical medical materials like lab specimens, pharmaceuticals, and supplies. The reliability of this service has a direct impact on patient care, diagnostic turnaround times, and overall hospital efficiency.
However, this critical role comes with significant challenges. The industry is governed by a web of complex regulations, including the FDA's Drug Supply Chain Security Act (DSCSA) and Good Distribution Practices (GDP), which demand rigorous compliance and investment in sophisticated tracking and verification systems. Furthermore, the COVID-19 pandemic exposed deep vulnerabilities in global supply chains, prompting a "great supply chain rethink" that prioritizes resilience, redundancy, and visibility.
Navigating these challenges requires astute financial stewardship. A strong CFO ensures the company can make the necessary capital investments in technology and infrastructure to meet regulatory demands and enhance supply chain resilience without compromising cost-efficiency. Liebโs experience in financial planning and transformation across complex organizations will be crucial in balancing these competing priorities, ensuring MedSpeed can continue to provide reliable service while maintaining its financial health and investing for the future.
As MedSpeed continues to expand through strategic partnerships, like its recent collaboration with WakeMed to build an integrated logistics network, strong financial leadership becomes even more essential. Lieb's role will be to ensure these complex integrations are executed efficiently and that the company is capitalized to meet the ever-evolving demands of a dynamic U.S. healthcare landscape.
๐ This article is still being updated
Are you a relevant expert who could contribute your opinion or insights to this article? We'd love to hear from you. We will give you full credit for your contribution.
Contribute Your Expertise โ